662 related articles for article (PubMed ID: 22821812)
21. Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals.
Hiraga T; Nakamura H
Int J Cancer; 2009 Jan; 124(1):215-22. PubMed ID: 18814279
[TBL] [Abstract][Full Text] [Related]
22. Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.
Abouantoun TJ; MacDonald TJ
Mol Cancer Ther; 2009 May; 8(5):1137-47. PubMed ID: 19417143
[TBL] [Abstract][Full Text] [Related]
23. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma.
Beckermann BM; Kallifatidis G; Groth A; Frommhold D; Apel A; Mattern J; Salnikov AV; Moldenhauer G; Wagner W; Diehlmann A; Saffrich R; Schubert M; Ho AD; Giese N; Büchler MW; Friess H; Büchler P; Herr I
Br J Cancer; 2008 Aug; 99(4):622-31. PubMed ID: 18665180
[TBL] [Abstract][Full Text] [Related]
24. Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression.
Beppu K; Jaboine J; Merchant MS; Mackall CL; Thiele CJ
J Natl Cancer Inst; 2004 Jan; 96(1):46-55. PubMed ID: 14709738
[TBL] [Abstract][Full Text] [Related]
25. Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice.
Pirson L; Baron F; Meuris N; Giet O; Castermans E; Greimers R; Di Stefano I; Gothot A; Beguin Y
Stem Cells; 2006 Jul; 24(7):1814-21. PubMed ID: 16614006
[TBL] [Abstract][Full Text] [Related]
26. Potential roles of growth factor PDGF-BB in the bony repair of injured growth plate.
Chung R; Foster BK; Zannettino AC; Xian CJ
Bone; 2009 May; 44(5):878-85. PubMed ID: 19442606
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C
J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
[TBL] [Abstract][Full Text] [Related]
28. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
Yener U; Avsar T; Akgün E; Şeker A; Bayri Y; Kılıç T
J Neurosurg; 2012 Oct; 117(4):697-704. PubMed ID: 22900848
[TBL] [Abstract][Full Text] [Related]
29. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
30. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ
J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539
[TBL] [Abstract][Full Text] [Related]
31. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
Peng Y; Li Z; Li Z
Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
[TBL] [Abstract][Full Text] [Related]
32. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
[TBL] [Abstract][Full Text] [Related]
33. Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells.
Kanehira M; Xin H; Hoshino K; Maemondo M; Mizuguchi H; Hayakawa T; Matsumoto K; Nakamura T; Nukiwa T; Saijo Y
Cancer Gene Ther; 2007 Nov; 14(11):894-903. PubMed ID: 17693990
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer.
Kikuchi H; Yagi H; Hasegawa H; Ishii Y; Okabayashi K; Tsuruta M; Hoshino G; Takayanagi A; Kitagawa Y
J Surg Res; 2014 Jul; 190(1):134-43. PubMed ID: 24679698
[TBL] [Abstract][Full Text] [Related]
35. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.
Takigawa H; Kitadai Y; Shinagawa K; Yuge R; Higashi Y; Tanaka S; Yasui W; Chayama K
Neoplasia; 2017 May; 19(5):429-438. PubMed ID: 28433772
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas.
Bexell D; Gunnarsson S; Tormin A; Darabi A; Gisselsson D; Roybon L; Scheding S; Bengzon J
Mol Ther; 2009 Jan; 17(1):183-90. PubMed ID: 18985030
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
